Published online Jun 15, 2002. doi: 10.3748/wjg.v8.i3.571
Revised: May 13, 2002
Accepted: May 25, 2002
Published online: June 15, 2002
AIM: To explore the relevance of Maotai liquor and liver diseases.
METHODS: Epidemiological study was conducted on groups of subjects, each consisting of 3 subjects from the Maotai liquor group consisting of 99 individuals and one from the non-alcoholic control group consisting of 33 individuals. Liver biopsy was performed on 23 volunteers from Guizhou Maotai Distillery who had a constant and long history of drinking Maotai liquor. Experimental histopathological study was conducted as follows: sixty male Wistar rats were divided into 3 groups randomly and fed with Maotai liquor, ordinary white wine, and physiological saline respectively for a period of 8 and 12 weeks. The rats were sacrificed in batches, then serum ALT, AST, TBil, and AKP were measured. Rat livers were harvested to measure the liver indexes, GSH, and MDA. Histopathological examinations were also performed. Another eighty mice were randomly divided into 4 groups and fed with Maotai (at different dosages of 10 mL·kg-1 and 20 mL·kg-1), ethanol, and physiological saline. The animals were sacrificed after 4 weeks and serum ALT was determined. Then the livers were harvested and liver indexes and MDA were measured.
RESULTS: The incidence rate of hepatic symptoms, splenomegaly, liver function impairment, reversal of Albumin/Globulin and increased diameter of portal veins in the Maotai liquor group were 1.0% (1/99), 1.0% (1/99), 1.0% (1/99), 1.0% (1/99), 0 (0/99) and 0 (0/99), 0 (0/99), 0 (0/99), 0 (0/99), 0 (0/99), respectively. There was no significant difference between the Maotai group and the non-alcoholic control group (P > 0.05). Various degree of fatty infiltration of hepatocytes was found in the 23 volunteers receiving liver biopsy, but there was no obvious hepatic fibrosis or cirrhosis. A comparison was made between the Maotai liquor group and the ordinary white wine group. It was found that hepatic MDA in rats and mice were 0.33 ± 0.10 and 0.49 ± 0.23 respectively in Maotai group and 0.61 ± 0.22 and 0.66 ± 0.32 in the ordinary white wine group; MDA had an obvious decrease in the Maotai liquor group (P < 0.05); hepatic GSH were 0.12 mg·g-1± 0.06 mg·g-1 in rats of the Maotai liquor group and (0.08 ± 0.02) mg·g-1 in white wine group, it was obviously increased in the Maotai liquor group (P < 0.05). After the 20 rats had been fed with ordinary white wine for 8 weeks consecutively, disarranged hepatocyte cords, fatty infiltration of hepatocytes, and fibrous septa of varying widths due to hepatic connective tissues proliferation were observed; after 12 weeks, the fibrous tissue proliferation continued and early cirrhosis appeared. Compared with the ordinary white wine group, fatty infiltration was observed in the 8-week and 12-week groups, but no necrosis or fibrosis or cirrhosis was found in the Maotai liquor group (P < 0.05).
CONCLUSION: Maotai liquor may cause fatty liver but not hepatic fibrosis or cirrhosis, and it can strengthen lipid peroxidation in the liver.
- Citation: Wu J, Cheng ML, Zhang GH, Zhai RW, Huang NH, Li CX, Luo TY, Lu S, Yu ZQ, Yao YM, Zhang YY, Ren LZ, Ye L, Li L, Zhang HN. Epidemiological and histopathological study of relevance of Guizhou Maotai liquor and liver diseases. World J Gastroenterol 2002; 8(3): 571-574
- URL: https://www.wjgnet.com/1007-9327/full/v8/i3/571.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i3.571
Alcohol can cause fatty liver, hepatitis and liver cirrhosis[1-5]. A lot of research showed that there was a close relationship between liver diseases and alcohol content of liquor. If one drinks ardent spirits 80 to 150 g daily for more than ten years, he will get alcoholic hepatitis, hepatic fibrosis, liver cirrhosis and even hepatocellular carcinoma[6-13]. Maotai liquor has a very unique brewing technique which is different from that for ordinary white wine, and there are multiple microorganisms in the special geographical situations which are able to absorb abundant amino acids, vitamins and many essential microelements[14], so the taste of Maotai is very sweet and pure. A study on 40 individuals reported by Li et al[13] showed that drinking Maotai liquor more than 150 g daily for ten years would not cause liver injury. Our previous study showed that Maotai liquor was able to induce increase of metallothioneins (MT), inhibit the proliferation of hepatic stellate cell (HSC) and generation of collagen and enhance the effect of antioxidation. Our study has initially interpreted the anti-fibrosis mechanism of Maotai liquor. A study was conducted on groups of subjects from Guizhou Maotai Distillery, each consisting of 3 subjects from the Maotai liquor group of 99 individuals who had a constant and long history of drinking Maotai liquor and one from the non-alcoholic control group of 33 individuals. Liver biopsy was performed on some of them and liver biopsy and serological tests in rats and mice fed with Maotai liquor were performed in order to explore the effect of Maotai liquor has on the liver.
One hundred and thirty two individuals from Guizhou Maotai Distillery, aged from 30 to 60 years old, were divided into Maotai liquor group consisting of 99 individuals and non-alcoholic control group consisting of 33 individuals. All members of the Maotai liquor group have the capacity for liquor of more than 250 g.d-1 and drinking history of longer than ten years. There was no significant difference between the two groups in sex and age. The male Wistar rats weighing (300 ± 20) g were employed in this study (Provided by Experimental Animal center, the Third Military Medical University); the mice of Kunming species weighing (22 ± 2) g (Provided by Experimental Animal center, Guiyang Medical College) were also used. Maotai liquor of (530 ± 2) g·L-1 was produced by Guizhou Maotai Distillery, China, whose code bar was 6902952880026; the ordinary white wine of (530 ± 2) g·L-1 was provided by the Fourth Department of Guizhou Food Export and Import Company.
Questionnaires were prepared in advance including sex, age, drinking history (capacity and duration), history of liver diseases, and history of gastropathy, etc. Physical examination, abdominal B ultrasound (the size of liver and spleen, diameter of portal vein), serum ALT, A/G, LN and HA were also done at the same time. Liver biopsy was performed in twenty three volunteers from the Maotai group, the liver tissue was fixed by formalin of 40 g·L-1, embedded by paraffin, sectioned and stained by HE. Sixty male Wistar rats were randomly divided into Maotai liquor group, ordinary white wine group and normal control group. Rats in the wine group were fed with 2 mL·kg-1 Maotai liquor and 2 mL·kg-1 ordinary white wine both of which were diluted one fold by distilled water, and in the control group were fed with the same volume of saline. All rats were fed once everyday continuously for 8 weeks, and after the last feed, 15 rats were fasted for 20 hours and then sacrificed to get blood for testing serum ALT, AST, TBil and AKP were tested, and Rat livers were harvested to measure the liver indexes, GSH, MDA, the liver tissue was embedded, sectioned and stained with HE. The remaining 5 rats in each group were sacrificed for histopathological examination after fed for 12 weeks. Eighty mice (40 male, 40 female) were randomly divided into 4 groups [two Maotai groups (at different dosage of 1 mL·kg-1 and 2 mL·kg-1), ethanol group, and physiological saline group]. Mice were fed with dosage of 1 mL·kg-1 and 2 mL·kg-1 Maotai in the two Maotai groups respectively. In the ethanol group, mice were fed (with) 53 g·L-1 ethanol at dosage of 1 mL·kg-1, they were fed once everyday for 4 weeks. After the last feed, the mice were killed to measure serum ALT, the liver indexes and MDA. Questionnaires were done by special messenger, and were examined and verified by persons in charge of the study.
The data were analyzed by t test and χ2 test.
The 98 individuals who had a long history of wine drinking had no symptoms abnormal, signs or liver function; only one who had a history of hepatitis showing cirrhosis of liver. He had symptoms of liver disease, splenomegaly, lightly increase of ALT and reversed A/G. There was no increase in the diameter of portal vein trunk in those individuals, compared with that of the control group, (P > 0.05). None of those who had a history of drinking Maotai for more than 30 years died of liver diseases. (See Table 1). There was a slight increase of serum LN, but a significant increase of HA, (P < 0.05) (See Table 2). All twenty three individuals in the Maotai group who had biopsy had varying degrees of fatty infiltration of hepatocytes. One of them had slight necrosis, but none had obvious hepatic fibrosis or cirrhosis of liver, in compared with that of the white wine group (P < 0.05).
Group | Number | Positive | ||
Number | Rate (%) | |||
History of liver disease | Maotai Group | 99 | 1 | 1.0 |
Control Group | 33 | 0 | 0 | |
Symptoms of liver disease | Maotai Group | 99 | 1 | 1.0 |
Control Group | 33 | 0 | 0 | |
Hepatomegaly | Maotai Group | 99 | 15 | 15.2 |
Control Group | 33 | 3 | 9.1 | |
Splenomegaly | Maotai Group | 99 | 1 | 1.0 |
Control Group | 33 | 0 | 0 | |
Abnormal ALT | Maotai Group | 99 | 1 | 1.0 |
Control Group | 33 | 0 | 0 | |
Reversed A/G | Maotai Group | 99 | 1 | 1.0 |
Control Group | 33 | 0 | 0 | |
Portal trunk widening | Maotai Group | 99 | 0 | 0 |
Control Group | 33 | 0 | 0 |
Neither Ordinary white wine nor Maotai liquor had obvious effect on ALT, AST, TBil, ALP and liver indexes in rats fed for 8 weeks, compared to the normal control group. There was no significant difference between them (P > 0.05) (See Table 3); but Maotai liquor was able to increase the level of GSH and decrease the level of liver MDA (See Table 4). There were no obvious pathologic changes in rat liver of the normal control group (See Figure 1). In the ordinary white wine group, all twenty rats had disarrangement of hepatocyte cords, fatty infiltration and hyperplasia of fibrous tissue which formed the fibrous septa (See Figure 2) after they had been fed for 8 weeks. The fibrous tissue had further hyperplasia in the rats of the 12-week group and there were also signs of early cirrhosis of liver (See Figure 3).But after the Maotai group had been fed for 8 weeks and 12 weeks, all rats had fatty infiltration, 17 were mild degree and 3 were moderate degree; all were devoided of necrosis of hepatocytes, hepatic fibrosis and cirrhosis (P < 0.05) (See Figure 4, Figure 5) when compared with that of the white wine group.
Group | Serum biochemical index | Liver index and biochemical index | |||||
ALT (nkat·L-1) | AST (nkat·L-1) | Tbil (nmol·L-1) | AKP (nkat·L-1) | Index (g·kg-1) | GSH (mg·g-1) | MDA (A) | |
Saline | 517 ± 233 | 300 ± 150 | 12.68 ± 6.47 | 350 ± 217 | 27.93 ± 8.64 | 0.06 ± 0.01 | 0.66 ± 0.24 |
Ordinary white wine | 567 ± 167 | 300 ± 67 | 13.54 ± 2.50 | 433 ± 67 | 29.19 ± 4.41 | 0.08 ± 0.02 | 0.61 ± 0.22 |
Maotai wine | 533 ± 183 | 283 ± 133 | 11.54 ± 6.20 | 450 ± 133 | 27.81 ± 2.11 | 0.12 ± 0.06a | 0.33 ± 0.10a |
About 40% of those who drank 150 g ardent spirits every day would have fatty liver and alcoholic hepatitis[15]. Alcoholic fatty liver diseases can be manifested as fatty liver, alcoholic hepatitis, hepatic fibrosis and cirrhosis of liver, frequently they are overlapping. And fatty liver can proceed to hepatic fibrosis via inflammatory progress. The varying pathology of alcoholic fatty liver diseases have similar pathogenesis in hepatic fibrosis and cirrhosis[16-22]. They are mainly caused by activation of HSC, resulting in excessive deposition and relatively insufficient degradation of ECM. Alcohol, acetaldehyde, lipid, fatty acids, etc can activate and stimulate Kupffer cells to secrete many cytokines which activate HSC to produce various components of ECM, as collagen, laminin, and hyaluronic acid, etc.
In recent years, studies have shown alcohol has direct damage effect to the hepatcytes[23-32]. Alcohol can be oxidized to acetaldehyde with elimination hydroxy free radicals, which causes lipid peroxidation, hepatocytic damage and apoptosis. Lipid peroxidation and its metabolic products malondialdehyde (MDA) and free radicals have strong cellular toxicity[33-37]. GSH[38-44] being an antioxidant is able to inhibit lipid peroxidation, and is also involved in hepatic detoxication, thus it can process cytoprotective effect. MT is a low molecular weight metal-binding protein rich in thioaminopropionic acid. Studies in recent years showed that MT has the effects of eliminating hydroxy free radicals and other oxidation products, being also protective[45-49].
Hepatic hatholigcal changes of human being and animals show that Maotai liquor can lead to fatty infiltration in the liver, but no obvious hepatic fibrosis or cirrhosis of liver. Similar findings were shown in epidemiological study, B mode ultrasound and liver biopsy in the Maotai liquor group One died of liver diseases in this group.
By contrast, various widths of fibrous septa and cirrhosis can be seen in the liver of rats fed ordinary white wine. Why is fatty infiltration in which Maotai liquor group dose not lead to liver fibrosis and cirrhosis of liver? The answer is that Maotai liquor was able to lower the MDA level in the rats and mice liver and increase the level of liver GSH as comparing with those in the. ordinary white wine group, P < 0.05. It also showed that Maotai liquor had the inhibitory effect on lipid peroxidation and was cytoprotective. Moreover, study in vitro showed that Maotai liquor could increase MT which was the most powerful bioactive substance of scavenging free radicals and antagonizing liver damage. Maotai liquor may also inhibit the activation of hepatic stellate cells and generation of collagen.
Our study revealed that Maotai liquor was able to elevate the level of workers’ serum LN and HA in Maotai liquor group vs. ordinary white wine group, (P < 0.05). It may be related with the activation of hepatic stellate cells (HSC) by ethanol, acetaldehyde, lipid and fatty acid. The elevation of LN was mild, but HA was very obvious whose reason may be that the serum level of HA was related with the ability of hepatic secretion and the renal excretion. In the acute hepatic injury caused by alcohol, inflammation and drugs, the level of serum HA may be very high, but it only points at a possible hepatic fibrosis or the early stage of hepatic fibrosis because researches show that the level of HA is not very high, even normal, in the late stage of hepatic fibrosis[50].
As one of the three most famous distilled sprits of the world, Maotai liquor was brewed with open solid state fermentation in a special geographical environment, so it has formed its own style which is hard for others to imitate. According to the analysis of the nutritive component in Maotai liquor in recent years, in every 100 mL Maotai Liquor, there were 18 mg protein, 6667 u superoxide dismutase (SOD), 0.06 mg vitamin B1, 0.1 mg vitamin B2 and 1.19 mg vitamin C, 0.022 mg manganese (Mn), 0.026 mg copper (Cu), 0.42 mg iron (Fe), 1.0 mg potassium (Ka), and < 0.005 mg zinc (Zn); 4.7 mg methanol, 4.7 mg aldehyde compounds. And there were also 18 kinds of amino acids and 6 kinds of essential amino acids except acimetion and tryptophan which were never found in the Jiang flavor white wine before Maotai. There were SOD and multiple human essential microelements in Maotai liquor, especially rich in Fe, Mn and Cu. The components of methanol, benzene and aldehyde were much lower than it was ruled in the international standard.
Edited by Wu XN
1. | Cheng ML, Liu SD. The basic study and clinical research on hepatic fibrosis. Renmin Weisheng Chubanshe. 1996;84-86. [Cited in This Article: ] |
2. | Sun YN. Recency studies in Pathogenesis of alcoholic liver diseases. Guowai Yiyao. Xiaohuaxi Jibing Fengce. 1999;19:97-101. [Cited in This Article: ] |
3. | Fan JG, Zeng MD, Wang GL. Pathogenesis of fatty liver. Shijie Huaren Xiaohua Zazhi. 1999;7:5-7. [Cited in This Article: ] |
4. | Tang TH. Recenctstudies of alcoholic liver diseases. Shijie Huaren Xiaohua Zazhi. 2000;8:56. [Cited in This Article: ] |
5. | Miyano S, Maeyama S, Iwaba A, Ogata S, Koike J, Kishi M, Uchikoshi T. A clinicopathological study of acute hepatitis in heavy drinkers, unrelated to hepatitis A, B, or C viruses. Alcohol Clin Exp Res. 2001;25:69S-74S. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
6. | Wu J, Liu RC, Li J, Wang WL, Hu L, Yang QZ, Liang YD, Lu YY, Cheng ML, Ding YS. To study the risk factors of hepatic cirrhosis in hepatitis virus and hepatic fibrosis. Cina Public Health. 1999;15:394. [Cited in This Article: ] |
7. | Wu J, Cheng ML, Ding YS, Liu RC, Li J, Wang WL, Hu L. Five years follow-up survey of risk factor of virus hepatic cirrhosis. Shijie Huaren Xiaohua Zazhi. 2000;8:1365-1367. [Cited in This Article: ] |
8. | Pan RM, Shao XD. Clinical characteristics of alcoholic liver disease. World J Gastroenterol. 1998;4:95-96. [Cited in This Article: ] |
9. | Huang Z, Tian DL, Yuan AH. Experimental animal models with alcoholic liver diseases. Huaren Xiaohua Zazhi. 1998;6:712-713. [Cited in This Article: ] |
10. | Liu WW. Etiological studies of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi. 1999;7:93-95. [Cited in This Article: ] |
11. | Gu GW, Zhou HG. New concept in etiology of liver cancer. Huaren Xiaohua Zazhi. 1998;6:185-187. [Cited in This Article: ] |
12. | Pan RM, Shao XD. Clinical characteristics of alcoholic liver disease. World J Gastroenterol. 1998;4:95-96. [Cited in This Article: ] |
13. | Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Crocè L, Sasso F, Pozzato G, Cristianini G. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut. 1997;41:845-850. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 437] [Cited by in F6Publishing: 395] [Article Influence: 14.6] [Reference Citation Analysis (0)] |
14. | Xiao Y. Preliminery explanation of the mechanism which long term drinking of GuiZhou maotai will not incur liver fibrosis. Zhonghua Yixue Zazhi. 2001;81628. [Cited in This Article: ] |
15. | Wang JY. Clinical Epidemiology of fatty liver. Zhonghua Ganzangbing Zazhi. 2000;8:115. [Cited in This Article: ] |
16. | Fan JG, Zeng MD, Hong J, Li JQ, Qiu DK. Effects of free unsaturated fatty acids on proliferation of L-02 and HLF cell lines and synthesis of extracellular matrix. Shijie Huaren Xiaohua Zazhi. 1998;6:502-504. [Cited in This Article: ] |
17. | Sun DL, Sun SQ, Li TZ, Lu XL. Serologic study on extracellular matrix metabolism in patients with viral liver cirrhosis. Huaren Xiaohua Zazhi. 1999;0:55-56. [Cited in This Article: ] |
18. | Lü XH, Xie YH, Fu BY, Liu CR, Wang BY. Dynamic expression of tissue inhibitor of metalloproteinase 1 in alcoholic liver disease in rats. Shijie Huaren Xiaohua Zazhi. 2001;9:29-33. [Cited in This Article: ] |
19. | Lu LG, Zeng MD, Li JQ, Fan JG, Hua J, Fan ZP, Dai N, Qiu DK. Effect of arachidonic acid and linoleic acid on proliferation of rat hepatic stellate cells. Shijie Huaren Xiaohua Zazhi. 1999;7:10-12. [Cited in This Article: ] |
20. | Kishore R, McMullen MR, Nagy LE. Stabilization of tumor necrosis factor alpha mRNA by chronic ethanol: role of A + U-rich elements and p38 mitogen-activated protein kinase signaling pathway. J Biol Chem. 2001;276:41930-41937. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 3.7] [Reference Citation Analysis (0)] |
21. | Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol. 2000;35:665-672. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 190] [Cited by in F6Publishing: 198] [Article Influence: 8.6] [Reference Citation Analysis (0)] |
22. | Anania FA, Womack L, Jiang M, Saxena NK. Aldehydes potentiate alpha(2)(I) collagen gene activity by JNK in hepatic stellate cells. Free Radic Biol Med. 2001;30:846-857. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 1.9] [Reference Citation Analysis (0)] |
23. | Ni R, Leo MA, Zhao J, Lieber CS. Toxicity of beta-carotene and its exacerbation by acetaldehyde in HepG2 cells. Alcohol Alcohol. 2001;36:281-285. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis (0)] |
24. | Zhang B, Zhang D, Ren H. [Resistance of Bcl-2 adenovirus vector to HepG(2) cell apoptosis induced by ethanol]. Zhonghua Ganzangbing Zazhi. 2000;8:215-217. [PubMed] [Cited in This Article: ] |
25. | Slukvin II, Boor PJ, Jerrells TR. Initiation of alcoholic fatty liver and hepatic inflammation with a specific recall immune response in alcohol-consuming C57Bl/6 mice. Clin Exp Immunol. 2001;125:123-133. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
26. | Deaciuc IV, Nikolova-Karakashian M, Fortunato F, Lee EY, Hill DB, McClain CJ. Apoptosis and dysregulated ceramide metabolism in a murine model of alcohol-enhanced lipopolysaccharide hepatotoxicity. Alcohol Clin Exp Res. 2000;24:1557-1565. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 2.7] [Reference Citation Analysis (0)] |
27. | Lu LG. Hepatic sieve and fatty liver. Zhonghua Ganzangbing Zazhi. 2000;8:115. [Cited in This Article: ] |
28. | Lin H, Lü M, Zhang YX, Wang BY, Fu BY. Induction of a rat model of alcoholic liver diseases. Shijie Huaren Xiaohua Zazhi. 2001;9:24-28. [Cited in This Article: ] |
29. | Bo AH, Tian CS, Xue GP, Du JH, Xu YL. Morphology of immuno and alcoholic liver diseases in rats. Shijie Huaren Xiaohua Zazhi. 2001;9:157-160. [Cited in This Article: ] |
30. | Yang CF, Chen XM, Liu J, Zheng WX, Chang W. Study of the effect of alcohol on liver lipid peroxidation in the rat. Xiandai Yufang Yixue. 1996;23:141-143. [Cited in This Article: ] |
31. | MacDonald GA, Bridle KR, Ward PJ, Walker NI, Houglum K, George DK, Smith JL, Powell LW, Crawford DH, Ramm GA. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J Gastroenterol Hepatol. 2001;16:599-606. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 110] [Cited by in F6Publishing: 105] [Article Influence: 4.6] [Reference Citation Analysis (0)] |
32. | Zima T, Fialová L, Mestek O, Janebová M, Crkovská J, Malbohan I, Stípek S, Mikulíková L, Popov P. Oxidative stress, metabolism of ethanol and alcohol-related diseases. J Biomed Sci. 2001;8:59-70. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 211] [Cited by in F6Publishing: 197] [Article Influence: 8.6] [Reference Citation Analysis (0)] |
33. | Lu XY. Mechanism of free radicals on liver injury induced by ethanal. Xin Xiaohuabingxue Zazhi. 1997;5:200-202. [Cited in This Article: ] |
34. | Degoul F, Sutton A, Mansouri A, Cepanec C, Degott C, Fromenty B, Beaugrand M, Valla D, Pessayre D. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology. 2001;120:1468-1474. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 86] [Cited by in F6Publishing: 93] [Article Influence: 4.0] [Reference Citation Analysis (0)] |
35. | Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med. 2000;21:49-98. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 457] [Cited by in F6Publishing: 443] [Article Influence: 18.5] [Reference Citation Analysis (0)] |
36. | Mutlu-Türkoğlu U, Doğru-Abbasoğlu S, Aykaç-Toker G, Mirsal H, Beyazyürek M, Uysal M. Increased lipid and protein oxidation and DNA damage in patients with chronic alcoholism. J Lab Clin Med. 2000;136:287-291. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 1.9] [Reference Citation Analysis (0)] |
37. | French SW. Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J Biomed Sci. 2001;8:20-27. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 61] [Cited by in F6Publishing: 69] [Article Influence: 3.0] [Reference Citation Analysis (0)] |
38. | Tang YP, Yang GZ, Lu HL, Tu YQ, Zhang Y. Effects of external glutathione in protection against organ in jury after infection. Zunyi Yixueyuan Xuebao. 1999;22:85-87. [Cited in This Article: ] |
39. | Shi JS, Sheng MP, Li F. protection from DEN carcinogenesis by glutathione in rat hepatoma model. Zunyi Yixueyuan Xuebao. 1998;21:1-5. [Cited in This Article: ] |
40. | Dai DW, Wu SM, Qi QE, Li M, Chen HJ, Chai W. Effects of glutamine on intracellular reduced glutathione in culturedhuman intestinal epithelial cells with anoxia/reoxygenation. Zhonghua Binglishengli Zazhi. 1999;15:128-130. [Cited in This Article: ] |
41. | Li J, Tu BQ, Yang TS, Liu JJ, Jia FM. Alteration of glutathione in RBC in patients with liver cirrhosis and its clinical significance. Xin Xiaohua Zazhi. 1996;4:18-19. [Cited in This Article: ] |
42. | Sun GY, Liu WW. Free radicals and Digestive system neoplasms. Huaren Xiaohua Zazhi. 1998;6:272-273. [Cited in This Article: ] |
43. | Soltys K, Dikdan G, Koneru B. Oxidative stress in fatty livers of obese Zucker rats: rapid amelioration and improved tolerance to warm ischemia with tocopherol. Hepatology. 2001;34:13-18. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 81] [Cited by in F6Publishing: 87] [Article Influence: 3.8] [Reference Citation Analysis (0)] |
44. | Yu JC, Jiang ZM, Li DM. Glutamine: a precursor of glutathione and its effect on liver. World J Gastroenterol. 1999;5:143-146. [PubMed] [Cited in This Article: ] |
45. | Nishimura N, Miyabara Y, Suzuki JS, Sato M, Aoki Y, Satoh M, Yonemoto J, Tohyama C. Induction of metallothionein in the livers of female Sprague-Dawley rats treated with 2,3,7 ,8-tetrachlorodibenzo-p-dioxin. Life Sci. 2001;69:1291-1303. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
46. | Park JD, Liu Y, Klaassen CD. Protective effect of metallothionein against the toxicity of cadmium and other metals(1). Toxicology. 2001;163:93-100. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 159] [Cited by in F6Publishing: 157] [Article Influence: 6.8] [Reference Citation Analysis (0)] |
47. | Wright J, George S, Martinez-Lara E, Carpene E, Kindt M. Levels of cellular glutathione and metallothionein affect the toxicity of oxidative stressors in an established carp cell line. Mar Environ Res. 2000;50:503-508. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
48. | Zaroogian G, Jackim E. In vivo metallothionein and glutathione status in an acute response to cadmium in Mercenaria mercenaria brown cells. Comp Biochem Physiol C Toxicol Pharmacol. 2000;127:251-261. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
49. | Fabisiak JP, Pearce LL, Borisenko GG, Tyhurina YY, Tyurin VA, Razzack J, Lazo JS, Pitt BR, Kagan VE. Bifunctional anti/prooxidant potential of metallothionenin: redox signaling of copper binding and release. Antioxid Redox Signal. 1999;1:349-364. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
50. | Kong XT. Early Diagnosis of hepatic fibrosis. Zhonghua Ganzangbing Zazhi. 2000;8:241-242. [Cited in This Article: ] |